All Guidance

To extend life or the time to mechanical ventilation for adult patients with amyotrophic lateral sclerosis (ALS) 1,2, variant of Motor Neurone Disease (MND). Safety and efficacy of riluzole has only been studied in ALS. Therefore, riluzole should not be used in patients with any other forms of MND. Riluzole should only be initiated by a neurological specialist with expertise in the management of MND (as per NICE TA 20, 2001)

It is expected that most patients will be managed by secondary care however this guideline is those patients who need to be managed in community

The purpose of this guidance is to provide clarity on the approval process for the prescribing of the second-generation antipsychotic long-acting injections within Lancashire Care NHS Foundation Trust. 

**This Guideline is currently under review. For further information please click here**

The purpose of this guidance is to outline recommendations for the prescribing of specialist infant formula milk within primary care in Lancashire and South Cumbria.

This guidance aims to support primary care in the prescription management process around cost-effective and rational prescribing for continence and stoma products.It is intended for all health care professionals and third party organisations involved in the prescribing, ordering and review of stoma and incontinence products within the Lancashire and South Cumbria Health Economy.

**This Guideline is currently under review. For further information please click here**

Licensed: Rheumatoid arthritis; ulcerative colitis, Crohn’s disease in adults and children
Unlicensed: Sero-negative spondyloarthropathy including psoriatic arthritis and psoriasis.

This position statement relates to the use of tapentadol MR for the following indications:

1. As a treatment option for intractable neuropathic pain in non-palliative care patients
2. As a treatment for nonspecific pain

For hypogonadism due to testosterone deficiency in adult men

Indication (licensed):Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

Unlicensed indication: As supplementation for postmenopausal women with low sexual desire if HRT alone is not effective.

Prescribing Information Sheet: To be read in conjunction with the relevant SPCs

Please note: NHSE has stated that GICs should retain responsibility for providing prescriptions and for monitoring until the GP has agreed to a transfer of responsibilities. Individual prescribers MUST only prescribe within their own level of competence

Prescribing Information Sheet: To be read in conjunction with the relevant SPCs

Please note: NHSE has stated that GICs should retain responsibility for providing prescriptions and for monitoring until the GP has agreed to a transfer of responsibilities. Individual prescribers MUST only prescribe within their own level of competence

Trans-anal Irrigation Systems are recommended for use within the Lancashire Health Economy for the treatment of Neurogenic Bowel Dysfunction and Non-Neurogenic Bowel Dysfunction including; chronic constipation and chronic faecal incontinence

This leaflet explains how some medicines are used differently to how they were originally developed and approved.

This position statement covers all single-ingredient preparations of vitamin D prescribed within the Lancashire NHS health economy for the management of deficiency and insufficiency states. This document is not intended to provide full guidance for the use of vitamin D within the NHS in Lancashire. Local protocols should also be consulted where they exist.

For additional prescribing information see Vitamin D Prescriber Resources in our Clinical Resources section